Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/002940 stock hub

SHE/002940 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/002940is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.3B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/002940

In the news

Latest news · SHE/002940

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E50.7

P25 23.5P50 41.3P75 83.2

ROE8.3

P25 -0.9P50 4.1P75 8.8

ROIC11.6

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/002940 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

229

Groups with data

Currency

CNY

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,275
Employees Change	-15%
Employees Change Percent	-1.16
Enterprise value	CNY 6.2B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100003GC2
Last refreshed	2026-05-10
Market cap	CNY 6.3B
Price	CNY 31.98
Price currency	CNY
Rev Per Employee	1,113,282.7x
Sector	Healthcare
Sic	2834
Symbol	she/002940
Website	https://www.alkpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.03%
EV Earnings	48.73x
EV/EBIT	30.28x
EV/EBITDA	22.19x
EV/FCF	39.78x
EV/Sales	4.37x
FCF yield	2.48%
P/B ratio	3.31x
P/E ratio	50.7x
P/S ratio	4.42x
PE Ratio10 Y	34.48x
PE Ratio3 Y	42.97x
PE Ratio5 Y	36.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.51%
EBITDA Margin	19.76%
FCF margin	10.98%
Gross margin	38.88%
Gross Profit	CNY 551.9M
Gross Profit Growth	-6.49%
Gross Profit Growth Q	-7.81%
Gross Profit Growth3 Y	-14.45%
Gross Profit Growth5 Y	-9.73%
Net Income	CNY 127.2M
Net Income Growth	86.98%
Net Income Growth Q	10.99%
Net Income Growth Years	0%
Net Income Growth3 Y	-2.03%
Net Income Growth5 Y	-3.84%
Pretax Margin	12.48%
Profit Margin	8.96%
Profit Per Employee	CNY 99,757
Profitable Years	11
ROA	4.27
Roa5y	3.78
ROCE	9.31
ROE	8.35
Roe5y	9.16
ROIC	11.58
Roic5y	12.44

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	136.09%
Cagr3y	18.09%
Cagr5y	19.11%
Div CAGR3	-9.14%
Div CAGR5	-1.1%
EPS Growth	85.59
EPS Growth Q	12.5
EPS Growth Years	0
EPS Growth3 Y	-2.11
EPS Growth5 Y	-4.67
FCF Growth	168%
FCF Growth3 Y	11.07%
FCF Growth5 Y	25.27%
OCF Growth	63.29%
OCF Growth3 Y	3.57%
OCF Growth5 Y	6.14%
Revenue Growth	-3.79x
Revenue Growth Q	-1.56x
Revenue Growth Years	0x
Revenue Growth3 Y	-4.98x
Revenue Growth5 Y	1.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.47
Assets	CNY 3.1B
Cash	CNY 891.1M
Current Assets	CNY 1.7B
Current Liabilities	CNY 903.9M
Debt	CNY 571.6M
Debt EBITDA	CNY 2.04
Debt Equity	CNY 0.3
Debt FCF	CNY 3.67
Equity	CNY 1.9B
Liabilities	CNY 1.2B
Long Term Assets	CNY 1.4B
Long Term Liabilities	CNY 319.4M
Net Cash	CNY 319.5M
Net Cash By Market Cap	CNY 5.09
Net Cash Growth	29.9%
Net Debt EBITDA	CNY -1.14
Net Debt Equity	CNY -0.17
Net Debt FCF	CNY -2.05
Tangible Book Value	CNY 1.2B
Tangible Book Value Per Share	CNY 6.18
WACC	7.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.84
Inventory Turnover	1.78
Net Working Capital	CNY 153.4M
Quick ratio	1.24
Working Capital	CNY 762.4M
Working Capital Turnover	CNY 1.99

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.75%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	CNY 0.2
Dividend Years	7
Dividend Yield	0.63%
Ex Div Date	2025-11-24
Last Dividend	CNY 0.1
Payout Frequency	Annual
Payout Ratio	25.66%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	135.95%
200-day SMA	39.22
3Y total return	64.7%
50-day SMA	32.56
50-day SMA vs 200-day SMA	50under200
5Y total return	139.73%
All Time High	68.8
All Time High Change	-53.52%
All Time High Date	2025-07-25
All Time Low	11.44
All Time Low Change	179.55%
All Time Low Date	2025-04-09
ATR	2.09
Beta	0.74
Beta1y	0.3
Beta2y	0.53
Ch YTD	-4.59
High	33.15
High52	68.8
High52 Date	2025-07-25
High52ch	-53.52%
Low	31.94
Low52	13.25
Low52 Date	2025-05-15
Low52ch	141.36%
Ma50ch	-1.78%
Price vs 200-day SMA	-18.47%
RSI	42.12
RSI Monthly	54.72
RSI Weekly	46.62
Sharpe ratio	1.58x
Sortino ratio	2.83
Total Return	-0.13%
Tr YTD	-4.59
Tr1m	-5.27%
Tr1w	-3.53%
Tr3m	-2.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 205.9M
Operating Income Growth	50.85
Operating Income Growth Q	-0.89
Operating Income Growth3 Y	10.32
Operating Income Growth5 Y	6.34
Operating margin	14.51

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	98,355,377%
Net Borrowing	43,780,399
Shares Insiders	11.19%
Shares Institutions	27.51%
Shares Out	196,108,486
Shares Qo Q	-7.33%
Shares Yo Y	0.75%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 155.8M
Average Volume	22,999,173.15x
Bv Per Share	8.39
CAPEX	CNY -43.8M
Ch1m	-5.27
Ch1w	-3.53
Ch1y	134.6
Ch3m	-2.2
Ch3y	59.84
Ch5y	127.7
Ch6m	-15.17
Change	-2.35%
Change From Open	-3.53
Close	32.75
Days Gap	1.22
Depreciation Amortization	74,543,753
Dollar Volume	352,227,528.1
Earnings Date	2026-04-29
EBIT	CNY 205.9M
EBITDA	CNY 280.4M
EPS	CNY 0.63
F Score	5
FCF	CNY 155.8M
FCF EV Yield	2.51x
FCF Per Share	CNY 0.79
Financing CF	-59,247,159
Fiscal Year End	December
Founded	2,001
Goodwill	312,941,911
Graham Number	10.91243
Graham Upside	-65.88
Income Tax	CNY 22.8M
Investing CF	-227,457,769
Is Primary Listing	1
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Date	2023-05-19
Last Split Type	Forward
Lynch Fair Value	CNY 3.15
Lynch Upside	-90.14
Ma150	35.58
Ma150ch	-10.11%
Ma20	34.86
Ma20ch	-8.27%
Net CF	-88,993,064
Next Earnings Date	2026-08-28
Open	33.15
P FCF Ratio	40.25
P OCF Ratio	31.42
Payment Date	2025-11-24
Position In Range	3.31
Ppne	616,437,917
Price Date	2026-05-08
Price EBITDA	CNY 22.36
Ptbv Ratio	5.17
Relative Volume	0.48x
Revenue	1,419,435,439x
Tax By Revenue	1.6x
Tax Rate	12.85%
Tr6m	-14.95%
Volume	11,013,994

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/002940 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.6%

$0.20 annual per share

Payout ratio

+25.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-1.1%

1 consecutive years of growth

Total shareholder yield

-0.1%

Next ex-dividend date: 2025-11-24

Performance

SHE/002940 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/002940?

Insider, institutional, and short-interest positioning.

Institutional ownership

+27.5%

Share of float held by funds and institutions

Insider ownership

+11.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.8%

Negative means the company is buying back shares.

Technical

SHE/002940 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.1

Neutral momentum band

Price vs 200-day MA

-18.5%

50/200-day relationship not available

Beta (5Y)

0.74

Less volatile than the market

Sharpe ratio

1.58

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/002940

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/002940 stock rating?

she/002940 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/002940 analysis?

The full report lives at /stocks/she/002940/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/002940?

The latest report frames she/002940 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/002940 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.